Alberto Rocci

Title: Alberto Rocci: Innovator in Hematological Diagnostics

Introduction

Alberto Rocci is a notable inventor based in Turin, Italy. He has made significant contributions to the field of hematological diagnostics through his innovative methods. His work focuses on improving the diagnosis and prognosis of hematological malignancies.

Latest Patents

Rocci holds a patent for a method of diagnosis and prognosis. This method involves measuring Gadd45β expression levels in a sample of cells, such as CD 138 expressing cells, obtained from a subject known to have or suspected of having a hematological malignancy. The expression levels can be utilized in diagnosing conditions like multiple myeloma, providing prognosis for patients, and guiding the selection of appropriate treatment agents, particularly those comprising Gadd45β and/or MKK7 inhibitors. His patent also includes datasets comprising measured expression levels from multiple subjects.

Career Highlights

Throughout his career, Rocci has worked with esteemed organizations, including Imperial College Innovations Limited and Imperial Innovations Limited. His expertise in the field has allowed him to develop methods that enhance the understanding and treatment of hematological conditions.

Collaborations

Rocci has collaborated with notable professionals in his field, including Guido Franzoso and Laura Tornatore. These collaborations have contributed to the advancement of research and innovation in hematological diagnostics.

Conclusion

Alberto Rocci's contributions to the field of hematological diagnostics through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to influence the diagnosis and treatment of hematological malignancies.